| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 4,309 | 4,798 | 5,649 | 7,289 |
| Net loss | -56,876 | -54,658 | -47,972 | -43,843 |
| Earnings per share, basic | -1.01 | -0.98 | -0.86 | -0.79 |
| Earnings per share, diluted | -1.01 | -0.98 | -0.86 | -0.79 |
| Weighted average number of shares outstanding, basic | 56,126,330 | 55,927,091 | 55,744,047 | 55,554,476 |
| Weighted average number of shares outstanding, diluted | 56,126,330 | 55,927,091 | 55,744,047 | 55,554,476 |
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)